ERBB2 and cancer: In this work, we tested the hypothesis that p95HER2- and full-length HER2-only overexpressing cancers exhibit distinct patterns of miRNA expression, which may serve both as diagnostic tools and as starting points for gaining new mechanistic insight into these differences.